The Artificial Retina Market is estimated at US$1.1 billion in 2026 and is projected to grow at a CAGR of 12.5% to reach US$2.8 billion by 2034.
Its value chain includes microelectronics suppliers, implant developers, ophthalmic surgeons, hospitals, rehabilitation providers, regulators, and research institutions. Core applications include retinal degeneration support, low vision rehabilitation, neurostimulation research, specialist ophthalmic surgery, and visual prosthesis development.
This product will be delivered within 1-3 business days.
Market Overview
The Artificial Retina Market covers implantable and neurostimulation based vision restoration technologies designed to provide partial visual function to patients with severe retinal degeneration or blindness.Its value chain includes microelectronics suppliers, implant developers, ophthalmic surgeons, hospitals, rehabilitation providers, regulators, and research institutions. Core applications include retinal degeneration support, low vision rehabilitation, neurostimulation research, specialist ophthalmic surgery, and visual prosthesis development.
Key Companies Analysed
- Pixium Vision
- Second Sight
- Bionic Vision Technologies
- Nidek
- Johnson & Johnson Vision
- Alcon
- Abbott
- Pixee Medical
- Vivani Medical
- LambdaVision
- Nano Retina
- Cortigent
- Neuralink
- Medtronic
- Santen
- Bausch + Lomb
- Retina Implant AG
- iBIONICS
- Nvision Biomedical
- Stanford Vision
Geographic Coverage
- North America - Market data and outlook to 2034
- United States
- Canada
- Mexico
- Europe - Market data and outlook to 2034
- Germany
- United Kingdom
- France
- Italy
- Spain
- Netherlands
- Switzerland
- Poland
- Sweden
- Russia
- Asia-Pacific - Market data and outlook to 2034
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Malaysia
- Vietnam
- Middle East and Africa - Market data and outlook to 2034
- Saudi Arabia
- South Africa
- Iran
- UAE
- Egypt
- South and Central America - Market data and outlook to 2034
- Brazil
- Argentina
- Chile
- Peru
Report Delivery and Support
- Updated PDF report and an MS Excel workbook containing market tables and figures.
- 7-day post-sale analyst support for clarifications and in-scope supplementary data.
- Complimentary report update covering the latest available data and relevant market developments.
This product will be delivered within 1-3 business days.
Table of Contents
1. Contents and Report Guide
2. Global Artificial Retina Market Overview
3. Artificial Retina Market Dynamics
4. Artificial Retina Market Strategic Analysis
5. Global Artificial Retina Market Size, Share and Forecast, 2025-2034
6. North America Artificial Retina Market Outlook to 2034
7. Europe Artificial Retina Market Outlook to 2034
8. Asia-Pacific Artificial Retina Market Outlook to 2034
9. Middle East and Africa Artificial Retina Market Outlook to 2034
10. South and Central America Artificial Retina Market Outlook to 2034
11. Artificial Retina Market Competitive Landscape
12. Appendix
Companies Mentioned
- Pixium Vision
- Second Sight
- Bionic Vision Technologies
- Nidek
- Johnson & Johnson Vision
- Alcon
- Abbott
- Pixee Medical
- Vivani Medical
- LambdaVision
- Nano Retina
- Cortigent
- Neuralink
- Medtronic
- Santen
- Bausch + Lomb
- Retina Implant AG
- iBIONICS
- Nvision Biomedical
- Stanford Vision
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 160 |
| Published | October 2026 |
| Forecast Period | 2026 - 2034 |
| Estimated Market Value ( USD | $ 1.1 Billion |
| Forecasted Market Value ( USD | $ 2.8 Billion |
| Compound Annual Growth Rate | 12.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 20 |
